KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Quest Diagnostics (DGX) Gross Margin (2016 - 2025)

Quest Diagnostics (DGX) has disclosed Gross Margin for 17 consecutive years, with 32.43% as the latest value for Q4 2025.

  • Quarterly Gross Margin fell 31.0% to 32.43% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 33.21% through Dec 2025, up 35.0% year-over-year, with the annual reading at 33.21% for FY2025, 35.0% up from the prior year.
  • Gross Margin hit 32.43% in Q4 2025 for Quest Diagnostics, down from 33.7% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 40.22% in Q1 2021 to a low of 32.17% in Q4 2023.
  • Historically, Gross Margin has averaged 34.55% across 5 years, with a median of 33.62% in 2024.
  • Biggest five-year swings in Gross Margin: surged 992bps in 2021 and later tumbled -490bps in 2022.
  • Year by year, Gross Margin stood at 37.39% in 2021, then dropped by -13bps to 32.49% in 2022, then fell by -1bps to 32.17% in 2023, then grew by 2bps to 32.74% in 2024, then dropped by -1bps to 32.43% in 2025.
  • Business Quant data shows Gross Margin for DGX at 32.43% in Q4 2025, 33.7% in Q3 2025, and 34.15% in Q2 2025.